These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 27107921)

  • 41. Management of venous thromboembolism in cancer patients.
    Lee AY; Levine MN
    Oncology (Williston Park); 2000 Mar; 14(3):409-17, 421; discussion 422, 425-6. PubMed ID: 10742967
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group.
    Schulman S; Granqvist S; Holmström M; Carlsson A; Lindmarker P; Nicol P; Eklund SG; Nordlander S; Lärfars G; Leijd B; Linder O; Loogna E
    N Engl J Med; 1997 Feb; 336(6):393-8. PubMed ID: 9010144
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The outpatient bleeding risk index: validation of a tool for predicting bleeding rates in patients treated for deep venous thrombosis and pulmonary embolism.
    Wells PS; Forgie MA; Simms M; Greene A; Touchie D; Lewis G; Anderson J; Rodger MA
    Arch Intern Med; 2003 Apr; 163(8):917-20. PubMed ID: 12719200
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of two methods for selection of out of hospital treatment in patients with acute pulmonary embolism.
    Zondag W; den Exter PL; Crobach MJ; Dolsma A; Donker ML; Eijsvogel M; Faber LM; Hofstee HM; Kaasjager KA; Kruip MJ; Labots G; Melissant CF; Sikkens MS; Huisman MV;
    Thromb Haemost; 2013 Jan; 109(1):47-52. PubMed ID: 23138355
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effect of lumbrokinase on patients with acute and moderate risk pulmonary thromboembolism].
    Jiang G; Zhang W; Peng M; Yan W
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Oct; 42(10):1156-1162. PubMed ID: 29093246
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Management of acute pulmonary embolism.
    Quadery R; Elliot CA; Hurdman J; Kiely DG; Maclean RM; Sabroe I; van Veen JJ; Condliffe R
    Br J Hosp Med (Lond); 2015 Oct; 76(10):C150-5. PubMed ID: 26457952
    [No Abstract]   [Full Text] [Related]  

  • 47. Low-molecular-weight heparins versus unfractionated heparin in the treatment of deep vein thrombosis and pulmonary embolism.
    Merli GJ
    Am J Phys Med Rehabil; 2000; 79(5 Suppl):S9-16. PubMed ID: 10994898
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tinzaparin in outpatients with pulmonary embolism or deep vein thrombosis.
    Dager WE; King JH; Branch JM; Chow SL; Ferrer RE; Pak S; Togioka PY; White RH
    Ann Pharmacother; 2005; 39(7-8):1182-7. PubMed ID: 15956232
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Thromboembolism.
    Fitzmaurice D; Hobbs FD; McManus R
    Clin Evid; 2002 Dec; (8):209-24. PubMed ID: 12603878
    [No Abstract]   [Full Text] [Related]  

  • 50. Anticoagulant therapy for venous thromboembolism.
    Raskob GE; Carter CJ; Hull RD
    Prog Hemost Thromb; 1989; 9():1-27. PubMed ID: 2643814
    [No Abstract]   [Full Text] [Related]  

  • 51. Treating patients with venous thromboembolism: initial strategies and long-term secondary prevention.
    Huisman MV; Bounameaux H
    Semin Vasc Med; 2005 Aug; 5(3):276-84. PubMed ID: 16123915
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adherence to Anticoagulant Therapy in Pediatric Patients Hospitalized With Pulmonary Embolism or Deep Vein Thrombosis: A Retrospective Cohort Study.
    Singh RR; Gupte-Singh KR; Wilson JP; Moffett BS
    Clin Appl Thromb Hemost; 2016 Apr; 22(3):260-4. PubMed ID: 26311289
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pulmonary embolism after brain hemorrhage in a hypertensive patient: the therapeutic dilemma.
    Oneglia C; Gualeni A
    J Thromb Thrombolysis; 2008 Apr; 25(2):231-4. PubMed ID: 17534695
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [When will a patient with pulmonary embolism be fit to go home?].
    Harjola VP
    Duodecim; 2015; 131(10):941-6. PubMed ID: 26237873
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rate and duration of hospitalization for deep vein thrombosis and pulmonary embolism in real-world clinical practice.
    Dentali F; Di Micco G; Giorgi Pierfranceschi M; Gussoni G; Barillari G; Amitrano M; Fontanella A; Lodigiani C; Guida A; Visonà A; Monreal M; Di Micco P
    Ann Med; 2015; 47(7):546-54. PubMed ID: 26422329
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Outpatient treatment of community acquired venous thromboembolism--the Christchurch experience.
    Heaton D; Han DY; Inder A
    N Z Med J; 2002 Jul; 115(1158):U105. PubMed ID: 12362180
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Longitudinal evaluation of health plan cost per venous thromboembolism or bleed event in patients with a prior venous thromboembolism event during hospitalization.
    Bullano MF; Willey V; Hauch O; Wygant G; Spyropoulos AC; Hoffman L
    J Manag Care Pharm; 2005 Oct; 11(8):663-73. PubMed ID: 16194130
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Summaries for patients. A comparison of two methods of starting the anticoagulant drug warfarin.
    Ann Intern Med; 2003 May; 138(9):I50. PubMed ID: 12729448
    [No Abstract]   [Full Text] [Related]  

  • 59. Thromboembolism.
    Fitzmaurice D; Hobbs FD; McManus R
    Clin Evid; 2002 Jun; (7):199-213. PubMed ID: 12230644
    [No Abstract]   [Full Text] [Related]  

  • 60. Treatment of deep vein thrombosis in patients with pulmonary embolism: subgroup analysis on the efficacy and safety of certoparin vs. unfractionated heparin.
    Riess H; Becker LK; Melzer N; Harenberg J
    Blood Coagul Fibrinolysis; 2014 Dec; 25(8):838-44. PubMed ID: 25004024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.